Contraceptive pill associated with increased prostate cancer risk worldwide, study finds
ScienceDaily (Nov. 14, 2011) Use of the contraceptive pill is associated with an increased risk of prostate cancer around the globe, finds research published in BMJ Open.
Prostate cancer is the most common male cancer in the developed world and the use of the contraceptive pill has soared over the past 40 years, state the authors.
The research team used data from the International Agency for Research on Cancer (IARC) and the United Nations World Contraceptive Use report to pinpoint rates of prostate cancer and associated deaths and the proportion of women using common methods of contraception for 2007.
They then analysed the data for individual nations and continents worldwide to see if there was any link between use of the contraceptive pill and illness and death caused by prostate cancer.
Their calculations showed that use of intrauterine devices, condoms, or other vaginal barriers was not associated with an increased risk of prostate cancer.
But use of the contraceptive pill in the population as a whole was significantly associated with both the number of new cases of, and deaths from, prostate cancer in individual countries around the world, the analysis showed. These findings were not affected by a nation’s wealth.
The authors emphasise that their research is speculative and designed to prompt further consideration of the issues. As such, their analysis does not confirm cause and effect, and therefore definitive conclusions can’t be drawn, as yet.
But they refer to several recent studies which have suggested that oestrogen exposure may boost the risk of prostate cancer.
Excess oestrogen exposure is known to cause cancer, and it is thought that widespread use of the Pill might raise environmental levels of endocrine disruptive compounds (EDCs) — which include by-products of oral contraceptive metabolism.
These do not break down easily, so can be passed into the urine and end up in the drinking water supply or the food chain, exposing the general population, state the authors.
“Temporal increases in the incidence of certain cancers (breast, endometrial, thyroid, testis and prostate) in hormonally sensitive tissues in many parts of the industrialised world are often cited as evidence that widespread exposure of the general population to EDCs has had adverse impacts on human health,” they write.
Recommend this story on Facebook, Twitter,
Other bookmarking and sharing tools:
The above story is reprinted from materials provided by BMJ Open.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
source : www.sciencedaily.com
Related News:
- New look at prolonged radiation exposure: At low dose-rate, radiation poses tiny risk to DNA, study suggests
- Toronto study links breakfast with school success
- Losing weight when obese can prevent or cure diabetes, whatever the initial BMI, study suggests
- Study links genes to common forms of glaucoma
- For Paul’s Believers, a Study in American Optimism
- Study points to potential treatment for stroke
- Memory loss with aging not necessarily permanent, animal study suggests
- Prolonged fructose intake not linked to rise in blood pressure, study suggests
- Inherited risk factors for childhood leukemia are more common in Hispanic patients, study finds
- Treatment of silent acid reflux does not improve asthma in children, study finds
Details :
Submited at Tuesday, November 15th, 2011 at 7:00 am on Health by steve
Comment RSS 2.0 - leave a comment - trackback